Paper32451908
Prediction of Maternal and Fetal Pharmacokinetics of Dolutegravir and Raltegravir Using Physiologically Based Pharmacokinetic Modeling.
Liu XI and 9 others. Clin Pharmacokinet, 2020. Cited by 21 papers, by iCite.
Cite this record
ConductScience Library. Prediction of Maternal and Fetal Pharmacokinetics of Dolutegravir and Raltegravir Using Physiologically Based Pharmacokinetic Modeling. Papers, record 32451908. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32451908
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Prediction of Maternal and Fetal Pharmacokinetics of Dolutegravir and Raltegravir Using Physiologically Based Pharmacokinetic Modeling.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| HIV Infections | Major topic |
| HIV Integrase Inhibitors | Major topic |
| Heterocyclic Compounds, 3-Ring | Major topic |
| Oxazines | Major topic |
| Piperazines | Major topic |
| Pyridones | Major topic |
| Raltegravir Potassium | Major topic |
| Female | |
| Fetus | |
| Humans | |
| Maternal Exposure | |
| Placenta | |
| Pregnancy | |
| Dolutegravir |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| T32 HD087969 | NICHD NIH HHS | United States | T32HD087969 | PubMed and NIH | NIH RePORTER |
| UM1 AI068616 | NIAID NIH HHS | United States | UM1AI068616 | PubMed and NIH | NIH RePORTER |
| UM1AI068632 | NIH | NIH RePORTER | |||
| UM1AI106716 | NIH | NIH RePORTER |
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT00042289 | Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy | Results |
Source ClinicalTrials.gov
References74
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16639716 | Physiologically based pharmacokinetic modelling 2: predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions. | J Pharm Sci | 2006 | https://conductscience.org/library/papers/16639716 | PubMed |
| 2 | 30265616 | Reconsidering the Number of Women With HIV Infection Who Give Birth Annually in the United States. | Public Health Rep | 2018 | https://conductscience.org/library/papers/30265616 | PubMed |
| 3 | 6796071 | The prenatal and postnatal development of UDP-glucuronyltransferase activity towards bilirubin and the effect of premature birth on this activity in the human liver. | Biochem J | 1981 | https://conductscience.org/library/papers/6796071 | PubMed |
| 4 | 3286084 | The significance of plasma protein binding on the fetal/maternal distribution of drugs at steady-state. | Clin Pharmacokinet | 1988 | https://conductscience.org/library/papers/3286084 | PubMed |
| 5 | 28401479 | Gestation-Specific Changes in the Anatomy and Physiology of Healthy Pregnant Women: An Extended Repository of Model Parameters for Physiologically Based Pharmacokinetic Modeling in Pregnancy. | Clin Pharmacokinet | 2017 | https://conductscience.org/library/papers/28401479 | PubMed |
| 6 | 18581209 | Cyclooxygenase inhibitors down regulate P-glycoprotein in human colorectal Caco-2 cell line. | Pharm Res | 2008 | https://conductscience.org/library/papers/18581209 | PubMed |
| 7 | 20457591 | Effect of low-, moderate-, and high-fat meals on raltegravir pharmacokinetics. | J Clin Pharmacol | 2011 | https://conductscience.org/library/papers/20457591 | PubMed |
| 8 | 19884365 | Pharmacokinetics and safety of S/GSK1349572, a next-generation HIV integrase inhibitor, in healthy volunteers. | Antimicrob Agents Chemother | 2010 | https://conductscience.org/library/papers/19884365 | PubMed |
| 9 | 11170034 | Prediction of adipose tissue: plasma partition coefficients for structurally unrelated drugs. | J Pharm Sci | 2001 | https://conductscience.org/library/papers/11170034 | PubMed |
| 10 | 28319246 | Estimated Perinatal HIV Infection Among Infants Born in the United States, 2002-2013. | JAMA Pediatr | 2017 | https://conductscience.org/library/papers/28319246 | PubMed |
| 11 | 26538508 | Placental transfer of the HIV integrase inhibitor dolutegravir in an ex vivo human cotyledon perfusion model. | J Antimicrob Chemother | 2016 | https://conductscience.org/library/papers/26538508 | PubMed |
| 12 | 15858854 | Physiologically based pharmacokinetic modeling 1: predicting the tissue distribution of moderate-to-strong bases. | J Pharm Sci | 2005 | https://conductscience.org/library/papers/15858854 | PubMed |
| 13 | 22945404 | A framework for elimination of perinatal transmission of HIV in the United States. | Pediatrics | 2012 | https://conductscience.org/library/papers/22945404 | PubMed |
| 14 | 26898568 | Effect of carbamazepine on dolutegravir pharmacokinetics and dosing recommendation. | Eur J Clin Pharmacol | 2016 | https://conductscience.org/library/papers/26898568 | PubMed |
| 15 | 17133211 | Antiretroviral activity, pharmacokinetics, and tolerability of MK-0518, a novel inhibitor of HIV-1 integrase, dosed as monotherapy for 10 days in treatment-naive HIV-1-infected individuals. | J Acquir Immune Defic Syndr | 2006 | https://conductscience.org/library/papers/17133211 | PubMed |
| 16 | 4520389 | Drug-protein binding in the newborn infant. | Ann N Y Acad Sci | 1973 | https://conductscience.org/library/papers/4520389 | PubMed |
| 17 | 32109493 | Impact of gastrointestinal physiology on drug absorption in special populations--An UNGAP review. | Eur J Pharm Sci | 2020 | https://conductscience.org/library/papers/32109493 | PubMed |
| 18 | 26552713 | Evaluation of the impact of multivalent metal ions on the permeation behavior of Dolutegravir sodium. | Drug Dev Ind Pharm | 2016 | https://conductscience.org/library/papers/26552713 | PubMed |
| 19 | 23515248 | Predicting intestinal absorption of raltegravir using a population-based ADME simulation. | J Antimicrob Chemother | 2013 | https://conductscience.org/library/papers/23515248 | PubMed |
| 20 | 24096683 | Pharmacokinetics of dolutegravir in HIV-seronegative subjects with severe renal impairment. | Eur J Clin Pharmacol | 2014 | https://conductscience.org/library/papers/24096683 | PubMed |
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42778687 | Modelling the tail-phase pharmacokinetics of long-acting cabotegravir and rilpivirine from early pregnancy to postpartum at steady state. | J Pharmacokinet Pharmacodyn | 2026 | https://conductscience.org/library/papers/42778687 | PubMed |
| 41983686 | Physiologically-based pharmacokinetic modelling of uridine 5'-diphosphoglucorosultransferase (UGT) substrate drugs in pregnant women. | Br J Clin Pharmacol | 2026 | https://conductscience.org/library/papers/41983686 | PubMed |
| 41221050 | Strategy advancements in placental pharmacokinetics: from in vitro experiments to in silico prediction. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/41221050 | PubMed |
| 39066420 | Safety and Efficacy of Antiviral Drugs and Vaccines in Pregnant Women: Insights from Physiologically Based Pharmacokinetic Modeling and Integration of Viral Infection Dynamics. | Vaccines (Basel) | 2024 | https://conductscience.org/library/papers/39066420 | PubMed |
| 38973651 | Labetalol Dosing in Pregnancy: PBPK/PD and CYP2C19 Polymorphisms. | J Clin Pharmacol | 2024 | https://conductscience.org/library/papers/38973651 | PubMed |
| 38517686 | Challenges, risks, and opportunities of antiretroviral drugs in women of reproductive potential. | Expert Rev Anti Infect Ther | 2024 | https://conductscience.org/library/papers/38517686 | PubMed |
| 38340019 | Physiologically-based pharmacokinetic modelling of long-acting injectable cabotegravir and rilpivirine in pregnancy. | Br J Clin Pharmacol | 2025 | https://conductscience.org/library/papers/38340019 | PubMed |
| 36365185 | Application of Physiologically Based Pharmacokinetic Modeling to Predict Maternal Pharmacokinetics and Fetal Exposure to Oxcarbazepine. | Pharmaceutics | 2022 | https://conductscience.org/library/papers/36365185 | PubMed |
| 34805038 | Maternal-Fetal Pharmacology of Drugs: A Review of Current Status of the Application of Physiologically Based Pharmacokinetic Models. | Front Pediatr | 2021 | https://conductscience.org/library/papers/34805038 | PubMed |
| 34733804 | Mechanistic Modeling of Placental Drug Transfer in Humans: How Do Differences in Maternal/Fetal Fraction of Unbound Drug and Placental Influx/Efflux Transfer Rates Affect Fetal Pharmacokinetics? | Front Pediatr | 2021 | https://conductscience.org/library/papers/34733804 | PubMed |
| 34722417 | Characterization of Plasma Protein Alterations in Pregnant and Postpartum Individuals Living With HIV to Support Physiologically-Based Pharmacokinetic Model Development. | Front Pediatr | 2021 | https://conductscience.org/library/papers/34722417 | PubMed |
| 34631628 | Mechanistic Coupling of a Novel in silico Cotyledon Perfusion Model and a Physiologically Based Pharmacokinetic Model to Predict Fetal Acetaminophen Pharmacokinetics at Delivery. | Front Pediatr | 2021 | https://conductscience.org/library/papers/34631628 | PubMed |
| 34616699 | Mechanistic Modeling of Maternal Lymphoid and Fetal Plasma Antiretroviral Exposure During the Third Trimester. | Front Pediatr | 2021 | https://conductscience.org/library/papers/34616699 | PubMed |
| 34381745 | Regulatory Considerations for the Mother, Fetus and Neonate in Fetal Pharmacology Modeling. | Front Pediatr | 2021 | https://conductscience.org/library/papers/34381745 | PubMed |
| 33527213 | Physiologically Based Pharmacokinetic Modeling Framework to Predict Neonatal Pharmacokinetics of Transplacentally Acquired Emtricitabine, Dolutegravir, and Raltegravir. | Clin Pharmacokinet | 2021 | https://conductscience.org/library/papers/33527213 | PubMed |
| 33041711 | The Revolution in Pediatric Drug Development and Drug Use: Therapeutic Orphans No More. | J Pediatr Pharmacol Ther | 2020 | https://conductscience.org/library/papers/33041711 | PubMed |
| 32748112 | Integration of physiological changes during the postpartum period into a PBPK framework and prediction of amoxicillin disposition before and shortly after delivery. | J Pharmacokinet Pharmacodyn | 2020 | https://conductscience.org/library/papers/32748112 | PubMed |
Genes10
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ABCB1 | 5243 | PubTator's text mining | https://conductscience.org/library/genes/5243 | NCBI Gene |
| AFP | 174 | PubTator's text mining | https://conductscience.org/library/genes/174 | NCBI Gene |
| ALB | 213 | PubTator's text mining | https://conductscience.org/library/genes/213 | NCBI Gene |
| CYP3A4 | 1576 | PubTator's text mining | https://conductscience.org/library/genes/1576 | NCBI Gene |
| FOLR1 | 2348 | PubTator's text mining | https://conductscience.org/library/genes/2348 | NCBI Gene |
| GAPDH | 2597 | PubTator's text mining | https://conductscience.org/library/genes/2597 | NCBI Gene |
| PRND | 23627 | PubTator's text mining | https://conductscience.org/library/genes/23627 | NCBI Gene |
| UGT1A1 | 54658 | PubTator's text mining | https://conductscience.org/library/genes/54658 | NCBI Gene |
| UGT1A3 | 54659 | PubTator's text mining | https://conductscience.org/library/genes/54659 | NCBI Gene |
| UGT1A9 | 54600 | PubTator's text mining | https://conductscience.org/library/genes/54600 | NCBI Gene |
Drugs40
The drugs whose trials, in the Pipelines release, list the paper.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32451908
GET https://conductscience.org/api/papers/v1/32451908/references?page=2